A citation-based method for searching scientific literature

Abdullah Alsuwaidan, Prasad Koduru, Franklin Fuda, Jesse Manuel Jaso, Mingyi Chen, Flavia Rosado, Hung S Luu, Nathan Sweed, Rolando Garcia, Meggie Doucet, Neil B Desai, Kiran A Kumar, Farrukh T Awan, Praveen Ramakrishnan Geethakumari, Weina Chen. Am J Clin Pathol 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin.
Ha Nguyen, Anamarija Perry, Pamela Skrabek, Michel Nasr, Alex F Herrera, Victoria Bedell, Joyce Murata-Collins, Raju Pillai, Minlin Xu, Lu Chen,[...]. J Mol Diagn 2021
2
50

The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.
Brett Collinge, Susana Ben-Neriah, Lauren Chong, Merrill Boyle, Aixiang Jiang, Tomoko Miyata-Takata, Pedro Farinha, Jeffrey W Craig, Graham W Slack, Daisuke Ennishi,[...]. Blood 2021
14
50

Double Hit Lymphoma Diagnosis and Treatment in Europe-A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG).
Igor Aurer, Martin Dreyling, Massimo Federico, Herve Tilly, Kim Linton, Eva Kimby, Martine E D Chamuleau, Marie Jose Kersten. Hemasphere 2020
2
50

Double-hit DLBCL: should we limit FISH testing?
Christiane Copie-Bergman. Blood 2018
7
50

Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance.
Kevin E Fisher, Lizmery S Ferguson, Amy M Coffey, Brian Y Merritt, Jonathan L Curry, Andrea N Marcogliese, Angela M Major, Kala Y Kamdar, Dolores H Lopez-Terrada, Choladda V Curry. Haematologica 2022
2
50

[The incidence of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in diffuse large B-cell lymphoma].
M Li, Q L Zhang, W Zhao, X Huang, L P Gong, Q F Shi, C L Liu, Z F Gao. Zhonghua Xue Ye Xue Za Zhi 2021
1
100



Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
Shigeru Kusumoto, Luca Arcaini, Xiaonan Hong, Jie Jin, Won Seog Kim, Yok Lam Kwong, Marion G Peters, Yasuhito Tanaka, Andrew D Zelenetz, Hiroshi Kuriki,[...]. Blood 2019
64
50

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.
Peifeng Li, Jia Chai, Zi Chen, Yang Liu, Jie Wei, Yixiong Liu, Danhui Zhao, Jing Ma, Kaijing Wang, Xia Li,[...]. Front Oncol 2021
5
50

Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy.
Martina Taborelli, Jerry Polesel, Maurizio Montella, Massimo Libra, Rosamaria Tedeschi, Monica Battiston, Michele Spina, Francesco Di Raimondo, Antonio Pinto, Anna Crispo,[...]. Infect Agent Cancer 2016
28
50

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
Jordan E Krull, Kerstin Wenzl, Keenan T Hartert, Michelle K Manske, Vivekananda Sarangi, Matthew J Maurer, Melissa C Larson, Grzegorz S Nowakowski, Stephen M Ansell, Ellen McPhail,[...]. Blood Cancer J 2020
7
50

Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Anna Dodero, Anna Guidetti, Fabrizio Marino, Alessandra Tucci, Francesco Barretta, Alessandro Re, Monica Balzarotti, Cristiana Carniti, Chiara Monfrini, Annalisa Chiappella,[...]. Haematologica 2022
5
50

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
50

PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.
Jinfeng Wang, Song Shang, Junjun Li, Hongyu Deng, Linda Ouyang, Hailong Xie, Haizhen Zhu, Yajun Li, Chaohui Zuo. Cancer Manag Res 2020
5
50

New developments in non-Hodgkin lymphoid malignancies.
Karthik A Ganapathi, Laura E Brown, Sonam Prakash, Parul Bhargava. Pathology 2021
5
50

MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
Shaoying Li, Parth Desai, Pei Lin, C Cameron Yin, Guilin Tang, Xuan J Wang, Sergej N Konoplev, Joseph D Khoury, Carlos E Bueso-Ramos, L Jeffrey Medeiros. Histopathology 2016
58
50

Advances in pathological understanding of high-grade B cell lymphomas.
Shaoying Li, Pei Lin, L Jeffrey Medeiros. Expert Rev Hematol 2018
11
50

The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
Chang-Ying Guo, Qian Zhu, Fang-Fang Tou, Xiao-Ming Wen, Yu-Kang Kuang, Hao Hu. BMC Cancer 2019
15
50

The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH.
Laura K Hilton, Jeffrey Tang, Susana Ben-Neriah, Miguel Alcaide, Aixiang Jiang, Bruno M Grande, Christopher K Rushton, Merrill Boyle, Barbara Meissner, David W Scott,[...]. Blood 2019
45
50

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.
David W Scott, Rebecca L King, Annette M Staiger, Susana Ben-Neriah, Aixiang Jiang, Heike Horn, Anja Mottok, Pedro Farinha, Graham W Slack, Daisuke Ennishi,[...]. Blood 2018
109
50

LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
Luis Colomo, Ivonne Vazquez, Natalia Papaleo, Blanca Espinet, Anna Ferrer, Catalina Franco, Laura Comerma, Silvia Hernandez, Xavier Calvo, Antonio Salar,[...]. Am J Surg Pathol 2017
13
50

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy.
Jinhua Liu, Zichao Chen, Yaqun Li, Wenjie Zhao, JiBiao Wu, Zhen Zhang. Front Pharmacol 2021
28
50

High-grade B-cell lymphomas with MYC and BCL2 translocations lack tumor-associated macrophages and PD-L1 expression: A possible noninflamed subgroup.
Marie F Breinholt, Douglas V N P Oliveira, Tobias W Klausen, Anne O Gang, Lone Schejbel, Mette Ø Pedersen, Mette V Elbaek, Erik Clasen-Linde, Signe L Nielsen, Helle Knudsen,[...]. Hematol Oncol 2021
5
50

Immune checkpoint inhibitors in lymphoma: challenges and opportunities.
Haris Hatic, Devi Sampat, Gaurav Goyal. Ann Transl Med 2021
8
50

Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Xi Zhou, Huaxiong Pan, Peng Yang, Pian Ye, Haiyan Cao, Hao Zhou. BMC Cancer 2019
21
50

Gastrointestinal non-Hodgkin lymphomas.
Magdalena Olszewska-Szopa, Tomasz Wróbel. Adv Clin Exp Med 2019
30
50

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.
Chi Young Ok, L Jeffrey Medeiros, Beenu Thakral, Guilin Tang, Nitin Jain, Elias Jabbour, Sherry A Pierce, Sergej Konoplev. Mod Pathol 2019
30
50

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
George W Wright, Da Wei Huang, James D Phelan, Zana A Coulibaly, Sandrine Roulland, Ryan M Young, James Q Wang, Roland Schmitz, Ryan D Morin, Jeffrey Tang,[...]. Cancer Cell 2020
270
50

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martinez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer,[...]. Blood 2022
29
50


The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici,[...]. Leukemia 2022
35
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.